Evaluación retrospectiva de la adherencia al tratamiento antihipertensivo en pacientes con eventos cardiovasculares previos

This review evaluated antihypertensive treatment adherence in patients with a history of cardiovascular events by analyzing studies published between 2020 and 2024. The objective was to identify patterns, associated factors, and potential strategies to improve adherence in this high-risk group. Studies included adult populations from various regions, with variability in age, sex, and socioeconomic status. Methods assessed adherence using pharmacy refill records, validated questionnaires, and clinical follow-up. Findings indicate that non-adherence is common and linked to higher risk of recurrent myocardial infarction, stroke, and cardiovascular mortality. Key barriers include treatment complexity, adverse effects, financial constraints, and lack of continuous medical follow-up. A general improvement trend in adherence was observed in recent years, partly attributed to telemedicine and educational programs, although significant gaps remain. We conclude that multifaceted interventions, including patient education, regimen simplification, financial support, and the use of reminder and monitoring technologies, are essential to optimize clinical outcomes.